Soliton Announces Global Nasdaq Partner Sanmina Delivers RAP Device to More Effectively Target Cellulite Reduction for Pivotal Trial Aug 1, 2019
Soliton Enlists Chicago Cosmetic Surgery and Dermatology to Advance Pivotal Cellulite Trial Jul 25, 2019
Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate Long-Term Improvement Jul 15, 2019
Soliton Announces Filing of Form S-1 Registering the Shares Issued in Private Placement at $14.00 per Unit Jul 2, 2019
